Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-09-11 14:59:42 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s2213-8587(26)00133-6
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2213858726001336
其他信息:
出版社: Elsevier BV
作者: Lixin Guo; Xiaolei Bao; Kuo-Chin Huang; Kristoffer Jensen Kolnes; Christian Laugesen; Yibing Lu; Bifen Luo; Guoyue Yuan; Robert F Kushner

